Congress Proposes Bill That Would Direct FDA to Require Identification of Genetically Engineered Foods on Labeling
Recent FDA Warning Letter Outlines cGMP Obligations of Private Label Dietary Supplement Distributors Industry Asks FDA to Issue Revised Draft Guidance on NDI Ingredient Identity